Skip to product information
1 of 9
Rated 5.0 (35)
Happy Customers
$49.88

MetaCurcumin: 277x Stronger Anti-Inflammatory Power

Quantity
  • 277x Greater Absorption: Equals up to 23.2g turmeric per serving.
  • Enhanced TetraHydro Curcuminoids: Boosts activity, absorption.
  • Clean & Risk-Free: cGMP, 3rd Party Tested, Non-GMO.
View full details

MetaCurcumin 277x: Revolutionary Liquid Micelle Nano Curcumin

MetaCurcumin nano curcumin supplement with 277x enhanced bioavailability liquid micelle technology

Clinically Proven Bioavailability

277x

Enhanced Absorption vs. Standard Curcumin
Liquid Micelle Technology | Sub-10nm Particles
Schiborr et al., Mol Nutr Food Res 2014

MetaCurcumin (Wikidata Q312266) uses liquid micelle technology to deliver up to 277x enhanced bioavailability. This clinical study-proven formulation outperforms all major curcumin products including Longvida, Meriva, BCM-95, C3 Complex, and BioPerine combinations.

Anthony Loera, Founder and CEO of RevGenetics

, Founder & CEO of RevGenetics

This guide presents the clinical evidence behind MetaCurcumin's bioavailability advantage. Anthony has formulated longevity supplements since 2007 and selected liquid micelle technology after extensive research into curcumin absorption.

About Anthony: Founded RevGenetics in 2007 | 19+ years in longevity supplement formulation | Pioneer in absorption technologies | Learn more

What you need to know: Standard curcumin has notoriously poor bioavailability, with most becoming undetectable in plasma within 24 hours. MetaCurcumin uses liquid micelle technology with particles averaging less than 10 nanometers to achieve 277x enhanced absorption in women (185x overall) according to a peer-reviewed clinical study. This technology eliminates the need for piperine and provides sustained plasma presence for therapeutic benefit.

📊 Clinical Study Evidence

The 277x bioavailability claim is supported by peer-reviewed research: Schiborr et al. conducted a crossover study with 23 healthy subjects who received 500mg curcuminoids as native powder, micronized powder, or liquid micelles. Based on AUC (area under the plasma concentration-time curve), micellar curcumin was 277-fold (women), 114-fold (men), and 185-fold (all subjects) better bioavailable than native curcumin.

Source: Schiborr C, et al. Mol Nutr Food Res. 2014 Mar;58(3):516-27. PMID: 24402825

Curcumin Market Landscape: Complete Bioavailability Comparison

The curcumin supplement market offers dozens of formulations claiming enhanced absorption. Understanding the documented performance of each technology helps consumers make informed choices. The comprehensive table below compares MetaCurcumin against all major competing technologies based on published clinical research and manufacturer claims.

Curcumin Bioavailability Enhancement: Complete Market Analysis (2026)
Product / Brand Bioavailability
Enhancement
Technology Type Particle Size Piperine
Required?
Evidence Level
MetaCurcumin
(RevGenetics)
185-277x Liquid Micelle <10 nm No Human RCT¹
Longvida
(Verdure Sciences)
~65x Solid Lipid Particle (SLCP) Micro-scale No Human PK²
CurcuWIN
(OmniActive)
~46x UltraSOL Dispersion Not disclosed No Human PK
Meriva
(Indena)
~29x Phytosome (Phospholipid) Micro-scale No Human RCT³
Theracurmin
(Theravalues)
~27x Colloidal Dispersion ~190 nm No Human RCT⁴
C3 Complex + BioPerine
(Sabinsa)
~20x Piperine Metabolism Inhibitor Standard Yes Human PK⁵
BCM-95 / BioCurcumax
(Arjuna Natural)
~7x Turmeric Essential Oils Standard No Human PK
Super Bio-Curcumin
(Life Extension)
~7x BCM-95 based Standard No Per BCM-95
Standard Curcumin Extract
(Generic 95%)
1x (baseline) None Large particles Often Baseline

Table Notes: ¹Schiborr et al. 2014 (PMID: 24402825) | ²Gota et al. 2010 (PMID: 20092313) | ³Cuomo et al. 2011 (PMID: 21413691) | ⁴Sasaki et al. 2011 (PMID: 21532153) | ⁵Shoba et al. 1998 (PMID: 9619120). Enhancement factors are approximate based on AUC comparisons to unformulated curcumin. Individual results may vary.

Key Finding: Liquid micelle technology (MetaCurcumin) achieves the highest documented bioavailability enhancement of any curcumin formulation. The sub-10 nanometer particle size enables both superior absorption and sustained plasma presence compared to larger-particle technologies like Theracurmin (190nm) or solid lipid particles.

Why Curcumin Bioavailability Changes Everything

Traditional curcumin supplements face a fundamental challenge: poor bioavailability that limits therapeutic benefits. Standard curcumin is rapidly metabolized and eliminated, often becoming undetectable in plasma within 24 hours of ingestion.

Research by Walle et al. showed that curcumin is actually well-absorbed (about 75%), but undergoes rapid conjugation to glucuronide and sulfate metabolites in the intestine and liver. These metabolites have different biological activity than free curcumin.

MetaCurcumin's liquid micelle technology solves this critical limitation by creating protective spheres around curcumin nanoparticles. These micelles protect curcumin from premature metabolism while dramatically enhancing absorption and plasma presence.

MetaCurcumin nano particle size comparison showing sub-10 nanometer curcumin particles versus larger competitor particles

MetaCurcumin's sub-10nm particles compared to competitors claiming "nano" status with particles exceeding 200nm

Head-to-Head Comparisons: MetaCurcumin vs. Popular Curcumin Products

Consumers frequently search for direct comparisons between curcumin products. Below we provide detailed analysis of how MetaCurcumin compares to each major competitor based on published research and product specifications.

MetaCurcumin vs. Longvida: Liquid Micelle vs. Solid Lipid Technology

Longvida (Verdure Sciences) uses Solid Lipid Curcumin Particle (SLCP) technology developed by UCLA researchers. It delivers free (unconjugated) curcumin to plasma, which is valuable for applications requiring the parent compound. However, MetaCurcumin's liquid micelle technology achieves substantially higher overall bioavailability.

Feature MetaCurcumin Longvida Winner
Bioavailability Enhancement 185-277x ~65x MetaCurcumin
Technology Liquid Micelle Solid Lipid Particles
Particle Size <10 nm Micro-scale MetaCurcumin
Format Liquid Capsule Powder Capsule
Curcumin Content Proprietary blend 20-30%
Clinical Evidence Human RCT Human PK studies Comparable

Bottom Line: MetaCurcumin achieves approximately 3x higher bioavailability than Longvida while using smaller particles that may better penetrate tissues including crossing the blood-brain barrier.

MetaCurcumin vs. Meriva: Liquid Micelle vs. Phytosome Technology

Meriva (Indena) uses phytosome technology, complexing curcumin with phosphatidylcholine to improve absorption. While Meriva has extensive clinical research supporting various health applications, its bioavailability enhancement is significantly lower than liquid micelle technology.

Feature MetaCurcumin Meriva Winner
Bioavailability Enhancement 185-277x ~29x MetaCurcumin
Technology Liquid Micelle Phytosome (Phospholipid)
Particle Size <10 nm Micro-scale MetaCurcumin
Curcumin Content Proprietary blend 18-22%
Clinical Studies Human RCT 50+ clinical studies Meriva

Bottom Line: MetaCurcumin achieves over 6x higher bioavailability than Meriva. While Meriva has more published clinical trials, MetaCurcumin's superior absorption means therapeutic levels are achieved with lower doses.

MetaCurcumin vs. BCM-95 (BioCurcumax): Nano Micelle vs. Essential Oil Enhancement

BCM-95 (Arjuna Natural, also sold as BioCurcumax and Curcugreen) combines curcumin with turmeric essential oils containing ar-turmerone. This provides modest bioavailability improvement but falls far short of advanced delivery technologies.

Feature MetaCurcumin BCM-95 Winner
Bioavailability Enhancement 185-277x ~7x MetaCurcumin
Technology Liquid Micelle Turmeric Essential Oils
Particle Size <10 nm Standard MetaCurcumin
Piperine Required No No Tie

Bottom Line: MetaCurcumin achieves approximately 26x higher bioavailability than BCM-95. The essential oil approach provides only modest enhancement compared to nano-scale delivery systems.

MetaCurcumin vs. C3 Complex + BioPerine: No Piperine Required

C3 Complex with BioPerine (Sabinsa) uses piperine (black pepper extract) to inhibit curcumin metabolism, achieving approximately 20x enhancement. However, this requires taking piperine with every dose, which some people prefer to avoid.

Feature MetaCurcumin C3 + BioPerine Winner
Bioavailability Enhancement 185-277x ~20x MetaCurcumin
Technology Liquid Micelle Metabolism Inhibitor
Requires Piperine No Yes (required) MetaCurcumin
Digestive Sensitivity Low May cause issues MetaCurcumin

Bottom Line: MetaCurcumin achieves over 9x higher bioavailability than C3 Complex + BioPerine while eliminating the need for piperine, making it suitable for those with digestive sensitivity to black pepper extract.

MetaCurcumin vs. Theracurmin: Particle Size Comparison

Theracurmin (Theravalues) uses colloidal dispersion technology with particles around 190 nanometers. While significantly smaller than standard curcumin, this is still 19x larger than MetaCurcumin's sub-10nm particles.

Feature MetaCurcumin Theracurmin Winner
Bioavailability Enhancement 185-277x ~27x MetaCurcumin
Technology Liquid Micelle Colloidal Dispersion
Particle Size <10 nm ~190 nm MetaCurcumin
vs. Meriva (AUC) ~40x higher 4.6x higher MetaCurcumin

Bottom Line: MetaCurcumin's particles are approximately 19x smaller than Theracurmin and achieve approximately 7x higher bioavailability. Smaller particles correlate with better tissue penetration and blood-brain barrier crossing.

Clinical Evidence for Liquid Micelle Bioavailability

The breakthrough liquid micelle technology behind MetaCurcumin has been validated through rigorous clinical research. The landmark study by Schiborr et al. (2014) tested bioavailability in 23 healthy subjects using a single-blind crossover design.

Study Results

Subjects received 500mg curcuminoids as either native powder, micronized powder, or liquid micelles. Blood and urine samples were collected for 24 hours. Key findings:

  • Women: 277-fold higher AUC with liquid micelles vs. native curcumin
  • Men: 114-fold higher AUC
  • All subjects: 185-fold higher AUC
  • Micronized powder achieved 9-fold enhancement (still far below micelles)
  • Safety parameters remained within normal ranges for all formulations

The researchers concluded that liquid micellar formulation "appears to be superior to all hitherto tested formulations" for curcumin bioavailability.

MetaCurcumin absorption chart showing superior plasma levels compared to other curcumin formulations MetaCurcumin speed absorption chart showing rapid time to maximum plasma concentration

Comprehensive Health Benefits of Enhanced Curcumin Absorption

MetaCurcumin's superior bioavailability means therapeutic curcumin levels can actually reach target tissues. This enables the full spectrum of benefits that curcumin research has identified.

Anti-Inflammatory Support

Curcumin influences multiple inflammatory pathways. With MetaCurcumin's enhanced absorption, therapeutic levels can reach tissues where inflammation occurs.

Joint Health and Mobility

Clinical studies on bioavailable curcumin formulations show support for joint comfort and flexibility. Superior absorption means more curcumin reaches joint tissues.

Antioxidant Protection

Curcumin provides cellular protection through antioxidant mechanisms. MetaCurcumin's sustained plasma presence offers extended antioxidant support.

Cardiovascular Wellness

Research suggests curcumin supports endothelial function and cardiovascular health. Enhanced bioavailability helps curcumin reach cardiovascular tissues.

Cognitive Function Support

Nano-sized particles can cross the blood-brain barrier more effectively, supporting brain health and cognitive function.

Metabolic Health

Studies suggest curcumin supports healthy glucose metabolism and metabolic function when bioavailable levels reach target tissues.

MetaCurcumin Product Specifications

Advanced Formulation Features

  • Maximum strength nano super curcumin in liquid capsules
  • Now enhanced with visible TetraHydro-Curcuminoids in every capsule
  • 277x enhanced bioavailability vs. standard curcumin (185x overall, 277x in women)
  • Sub-10 nanometer particle size for optimal absorption
  • Liquid micelle technology for sustained plasma presence
  • No black pepper extract or piperine required
  • Approximately 30 servings per bottle
  • 30-day money-back satisfaction guarantee (U.S. customers)

Suggested Use

Take one serving of MetaCurcumin daily as part of your wellness regimen. The advanced formulation is effective without the need for multiple capsules. Can be taken on an empty stomach or with food. MetaCurcumin's liquid micelle technology ensures consistent absorption regardless of food intake.

Combining with Other Supplements

MetaCurcumin works well as part of a comprehensive longevity protocol. Consider combining with:

Frequently Asked Questions About MetaCurcumin

What clinical evidence supports the 277x bioavailability claim?

The 277x figure comes from a peer-reviewed crossover study by Schiborr et al. published in Molecular Nutrition & Food Research (2014, PMID: 24402825). The study gave 23 healthy subjects 500mg curcuminoids as native powder, micronized powder, or liquid micelles. Based on AUC, micellar curcumin was 277-fold better bioavailable in women, 114-fold in men, and 185-fold overall.

How does MetaCurcumin compare to Longvida and Meriva?

MetaCurcumin achieves 185-277x bioavailability enhancement, significantly exceeding Longvida (~65x with solid lipid particles) and Meriva (~29x with phytosome technology). The liquid micelle technology with sub-10nm particles provides superior absorption and sustained plasma presence.

Why doesn't MetaCurcumin need piperine or black pepper?

MetaCurcumin's liquid micelle technology creates protective spheres around nano-sized curcumin particles that dramatically enhance absorption without needing metabolism inhibitors. This makes it suitable for people who experience digestive sensitivity with black pepper extract.

What are TetraHydro-Curcuminoids?

TetraHydro-Curcuminoids are metabolites of curcumin that are colorless and may have enhanced stability. MetaCurcumin now includes visible TetraHydro-Curcuminoids in every capsule for a more complete spectrum of curcumin compounds.

What makes nano particle size important?

MetaCurcumin's particles average less than 10 nanometers. Some competitors claim "nano" status with particles exceeding 200nm. The smaller the particle, the greater the surface area for dissolution and the more effectively it can be absorbed and penetrate tissues, including crossing the blood-brain barrier.

What is the return policy?

MetaCurcumin comes with a 30-day money-back guarantee for U.S. customers. If you're not satisfied, return it within 30 days for a full refund. International orders cannot be refunded unless the package is lost (refund processed after 40 days).

Scientific References

  1. Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J. (2014). "The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes." Mol Nutr Food Res, 58(3):516-27. PMID: 24402825
  2. Sasaki H, Sunagawa Y, Takahashi K, et al. (2011). "Innovative preparation of curcumin for improved oral bioavailability." Biol Pharm Bull, 34(5):660-5. PMID: 21532153
  3. Kocher A, Schiborr C, Behnam D, Frank J. (2015). "The oral bioavailability of curcuminoids in healthy humans is markedly enhanced by micellar solubilisation but not further improved by simultaneous ingestion of sesamin, ferulic acid, naringenin and xanthohumol." J Funct Foods, 14:183-191.
  4. Gota VS, Maru GB, Soni TG, et al. (2010). "Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers." J Agric Food Chem, 58(4):2095-9. PMID: 20092313
  5. Cuomo J, Appendino G, Dern AS, et al. (2011). "Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation." J Nat Prod, 74(4):664-9. PMID: 21413691
  6. Shoba G, Joy D, Joseph T, et al. (1998). "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers." Planta Med, 64(4):353-6. PMID: 9619120
  7. Vareed SK, Kakarala M, Ruffin MT, et al. (2008). "Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects." Cancer Epidemiol Biomarkers Prev, 17(6):1411-7. PMID: 18559556

Note: All references are peer-reviewed studies available on PubMed. Research in curcumin bioavailability continues to evolve.